📣 The Announcement

China Pharma Holdings (NYSE American: CPHI) put out a short but specific statement. Its stock saw unusual trading activity on July 10, 13, and 15, 2026, and the NYSE American reached out to ask what was going on.

The company's reply, in plain English: we have no idea. It says there is no undisclosed news, deal, or business development that would explain the sudden moves.

👉 In short, management is telling investors: don't read a secret story into our share price — we aren't sitting on anything we haven't already told you.

🏢 Company Context

👉 In simple terms, China Pharma is a specialty drugmaker based in Haikou, in China's Hainan Province, operating through its subsidiary Hainan Helpson Medical & Biotechnology.

It develops, manufactures, and sells medicines aimed at some of China's biggest health problems — cardiovascular disease, central nervous system (CNS) conditions, infections, and digestive illnesses. These are areas with high patient numbers and high mortality, so demand is steady.

The company runs eight GMP-certified product lines. GMP stands for Good Manufacturing Practice, a regulatory quality standard — think of it as the government's stamp that a factory is clean, consistent, and safe enough to make medicine.

💥 Why It Matters

When a stock jumps or dives sharply for no obvious reason, exchanges like the NYSE American routinely call the company to check nothing is being hidden. This is a normal investor-protection step, not an accusation.

By law and by exchange rules, companies must disclose material information to everyone at the same time. A statement like this exists to keep the market fair and to protect the company from claims that it leaked or withheld news.

👉 The signal here is neutral: the company is following the rulebook, and it is publicly denying that any secret catalyst is driving the trading.

📊 By The Numbers

The hard facts in this release are dates, not dollars. The unusual activity occurred on three trading days: July 10, 13, and 15, 2026.

The stock trades on the NYSE American under the ticker CPHI. There are no earnings figures, guidance changes, or financial targets in this notice — that absence is the whole point.

🔍 The Details

Companies generally have a policy of not commenting on market moves at all, because share prices swing for countless reasons — rumors, momentum traders, or broad market swings. China Pharma notes it usually stays quiet too.

Here it made an exception only because the exchange asked. Its careful wording — no "material nonpublic information" and no undisclosed "business developments" — is legal language meaning nothing important is being kept off the public record.

🔮 What's Next

There is no event, call, or deadline attached to this notice. The company simply says it routinely posts important information on its website, chinapharmaholdings.com.

👉 If a real catalyst emerges later, it would come through a separate filing or press release — this statement commits the company to nothing beyond honesty about the present.

Contact: China Pharma Holdings, Inc., Phone +86-898-6681-1730 (China).

⚖️ Upside & Risks

👍 Strength: prompt, transparent cooperation with the exchange builds credibility and reduces the risk of misinformation spreading among traders.

⚠️ Risk: unexplained volatility can be a red flag for retail investors, who may be buying or selling on rumor rather than facts. A small-cap stock like this can move violently on thin trading, so "no news" does not mean "no danger."

🧠 The Analogy

Imagine a store's alarm suddenly goes off three times in a week. Security calls the owner and asks, "Was there a break-in?" The owner checks everything and says, "Nothing's missing, nothing's wrong — I don't know why it's ringing." That's exactly this statement: the alarm is the stock's unusual trading, and the owner is confirming there's no hidden emergency behind it.

🧩 Final Takeaway

China Pharma's stock moved sharply, the exchange asked why, and the company says there's no undisclosed reason. It's a routine transparency notice — reassuring on honesty, but a reminder that unexplained swings in a small stock deserve caution.